Alternating modified CAPOX/CAPIRI plus bevacizumab shows promising activity in untreated unresectable metastatic colorectal cancer in a phase 2 trial.
Advancing first-line combination strategies.
doi.org/10.1038/s413...
#MetastaticColorectalCancer #CAPOX #CAPIRI #Bevacizumab #ClinicalOncology
Unlock biomarker insights & responder profiles from #FFPE samples.
Sapient’s FFPE Multi-Omics Platform analyzes archived tissue to:
• Optimize stratification & dosing
• Identify target engagement
• Select responder subgroups
#ClinicalOncology study: lnkd.in/ghg4qHSa
📝Access mCRPC treatment guidance in seconds with ONCOassist
#mCRPC #ProstateCancer #OncologyTools #CancerCare #ClinicalOncology #DigitalHealth #OncologyApp #AdvancedProstateCancer #oncologytools
📝Access CTCAE v6 toxicity grading in seconds in ONCOassist
The CTCAE criteria are designed to standardise adverse event reporting in oncology research and practice.
#ONCOassist #CTCAEv6 #ToxicityGrading #AdverseEvents #OncologyTools #DigitalHealth #CancerCare #ClinicalOncology #OncologyApp
📣 IOF Webinar 🗓 13 Nov 2025 | 17:00 CET
🦴 AIBL management in women with breast cancer
Learn about fracture risk assessment, bone health monitoring + latest evidence on bone-protective therapies.
👉 Register: bit.ly/47u0Xs4
#BoneHealth #ClinicalOncology #AIBL #osteoporosis
#BreastCancerResearch #AdjuvantTherapy #CancerOutcomes #OncologyResearch #RadiationTherapy #CancerTreatment #MSKResearch #ClinicalOncology #CancerSurvivorship #MSKInnovation #JAMANetworkOpen
'Real-World Analysis of the Correlation between Overall Survival and Progression-Free Survival in Advanced Pancreatic Cancer: Results of NAPOLEON-1 and 2 Studies' - a @kargerpublishers.bsky.social #DigitalHealth article:
#️⃣ #CancerResearch #PancreaticCancer #ClinicalOncology
🌅Our July issue is online🌄
🔖Thematic issue on ‘Liquid Biopsy and Precision Oncology’ highlighting diverse approaches utilized in liquid biopsy research & clinical applications
🔓 buff.ly/3I7WAHM
#LiquidBiopsies #ctDNA #CTC #ctDNA #CancerResearch #ClinicalOncology
#BrainMetastases (BM) from #PancreaticCancer are rare. However, in 41% of cases, BM was the first sign of spread. Early neuroimaging in high-risk patients may enable earlier diagnosis and improve outcomes.
#Oncology #PrecisionOncology #ClinicalOncology #NeuroOncology #MetastaticCancer
🚨 Just released: CAP updates its cancer reporting protocols — a must-read for oncologists ahead of #ASCO25.
🧠 Precision starts with pathology. Stay ahead of the curve.
🔗 ascopost.com/news/april-2...
#Oncology #CancerResearch #CAP #Pathology #ClinicalOncology #PrecisionMedicine
A phase II trial reports that short-course ADT combined with SBRT improved progression-free survival in patients with hormone-sensitive oligorecurrent prostate cancer.
ascopost.com/news/march-2...
#ProstateCancer #ClinicalOncology
Great news for #TeamManchester!
Our very own Dr Nicky Thorp #TheChristie has just been elected as Vice President #ClinicalOncology for the Royal College of Radiologists. We are in excellent hands! 🌟
@mcrcnews.bsky.social
Have a listen 👇🏼
Clinical oncology is just the best specialty - could it be for you?
#ClinicalOncology
#OncologyTraining
Member Spotlight: Stephen Yip
Dr. Stephen Yip is a #neuropathologist at Vancouver General Hospital and medical director of Clinical Cancer Genomics at BC Cancer. His interests lie in the molecular pathogenesis of #BrainCancer and the practical deployment of advanced diagnostic tools in #ClinicalOncology.
@syip.bsky.social
Thanks for putting this together Richard. Such a great idea! #MedicalOncology 🤝 #ClinicalOncology 😀
#MedSky🧪 #Clinicaloncology The new bispecific Rx #ivonescimab has outperformed #PD1checkpointinhibitor Keytruda (pembrolizumab) in a head-to-head #clinicaltrial of NSCLC . The dual-action #VEGF–PD-1 antibody nearly doubled progression-free survival over the PD-1 blocker
rdcu.be/dW0kn
The “clouds of complexity” impinging on the frontiers of cancer biology and cancer medicine
The interplay between cancer driver mutations and environmental or endogenous tumor promoters in cancer risk
Tumor micro- and macro-environments
Local and systemic drivers of protumorigenic myeloid dysregulation
MedSky🧪 #ClinicalOncology #Cancerbiology #Immunooncology Understanding cancer complexity: Hallmarks of systemic disease & mechanisms of #carcinogenesis .Multistep #tumorigenesis in tumor promotion & progression
www.cell.com/cell/fulltex...
